Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Synbio International Inc. secures rights to conduct clinical trials for AI-powered depression screening technology (NIMS: Non ...

More than 280 million people live with depression, according to the World Health Organization. People experience the ...

A real-world analysis suggests antidepressants may lead to faster cognitive decline in patients with dementia, but experts ...

The depression treatment market is experiencing steady growth, driven by rising mental health awareness, increasing prevalence of depression, and advancements in novel therapies. The market is ...

Though girls reported greater depression and anxiety symptoms, there were generally no health inequities at inpatient psychiatric unit discharge.

Some studies link GLP-1 drugs for diabetes with neuroprotective benefits but others say that some of these drugs may increase ...

Psilocybin therapy significantly decreased moderate to severe symptoms of depression in clinicians after frontline work ...

Medication does not ‘cure’ clinical depression. According to JHM, meds that once worked for someone might over time become ...

The FDA has approved adaptive deep brain stimulation (aDBS), a breakthrough therapy that adjusts in real time to Parkinson’s disease symptoms.

Synbio International Inc. secures rights to conduct clinical trials for AI-powered depression screening technology (NIMS: Non-invasive Mental Screening).NIMS is a fast, highly accurate and cost-effect ...